JPWO2020005877A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020005877A5
JPWO2020005877A5 JP2020572894A JP2020572894A JPWO2020005877A5 JP WO2020005877 A5 JPWO2020005877 A5 JP WO2020005877A5 JP 2020572894 A JP2020572894 A JP 2020572894A JP 2020572894 A JP2020572894 A JP 2020572894A JP WO2020005877 A5 JPWO2020005877 A5 JP WO2020005877A5
Authority
JP
Japan
Prior art keywords
methyl
thiazolo
benzothiazole
fluoro
indazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020572894A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021528466A (ja
JP7515415B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/038895 external-priority patent/WO2020005877A1/en
Publication of JP2021528466A publication Critical patent/JP2021528466A/ja
Publication of JPWO2020005877A5 publication Critical patent/JPWO2020005877A5/ja
Priority to JP2024072881A priority Critical patent/JP2024105367A/ja
Application granted granted Critical
Publication of JP7515415B2 publication Critical patent/JP7515415B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020572894A 2018-06-27 2019-06-25 ハンチントン病を処置するためのヘテロアリール化合物 Active JP7515415B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024072881A JP2024105367A (ja) 2018-06-27 2024-04-26 ハンチントン病を処置するためのヘテロアリール化合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862690540P 2018-06-27 2018-06-27
US62/690,540 2018-06-27
PCT/US2019/038895 WO2020005877A1 (en) 2018-06-27 2019-06-25 Heteroaryl compounds for treating huntington's disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024072881A Division JP2024105367A (ja) 2018-06-27 2024-04-26 ハンチントン病を処置するためのヘテロアリール化合物

Publications (3)

Publication Number Publication Date
JP2021528466A JP2021528466A (ja) 2021-10-21
JPWO2020005877A5 true JPWO2020005877A5 (pt) 2022-06-21
JP7515415B2 JP7515415B2 (ja) 2024-07-12

Family

ID=67185796

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020572894A Active JP7515415B2 (ja) 2018-06-27 2019-06-25 ハンチントン病を処置するためのヘテロアリール化合物
JP2024072881A Abandoned JP2024105367A (ja) 2018-06-27 2024-04-26 ハンチントン病を処置するためのヘテロアリール化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024072881A Abandoned JP2024105367A (ja) 2018-06-27 2024-04-26 ハンチントン病を処置するためのヘテロアリール化合物

Country Status (13)

Country Link
US (1) US20210284660A1 (pt)
EP (1) EP3814345B8 (pt)
JP (2) JP7515415B2 (pt)
KR (1) KR20210038845A (pt)
CN (1) CN112805280A (pt)
AU (2) AU2019294482B2 (pt)
BR (1) BR112020026534A2 (pt)
CA (1) CA3104516A1 (pt)
EA (1) EA202092899A1 (pt)
IL (1) IL279714A (pt)
MX (1) MX2020014315A (pt)
SG (1) SG11202012869SA (pt)
WO (1) WO2020005877A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3119019C (en) 2015-12-10 2024-06-11 Ptc Therapeutics, Inc. Compounds and methods for treating huntington's disease
SG11201911615WA (en) 2017-06-05 2020-01-30 Ptc Therapeutics Inc Compounds for treating huntington's disease
US11395822B2 (en) 2017-06-28 2022-07-26 Ptc Therapeutics, Inc. Methods for treating Huntington's disease
BR112019027717A2 (pt) 2017-06-28 2020-07-28 Ptc Therapeutics, Inc. métodos para tratar a doença de huntington
GB2579747B8 (en) 2017-08-04 2022-10-05 Skyhawk Therapeutics Inc Methods and compositions for modulating splicing
US12103926B2 (en) 2018-03-27 2024-10-01 Ptc Therapeutics, Inc. Compounds for treating huntington's disease
LT3814357T (lt) 2018-06-27 2024-06-25 Ptc Therapeutics, Inc. Heterocikliniai ir heteroarilų junginiai, skirti hantingtono ligos gydymui
US11685746B2 (en) 2018-06-27 2023-06-27 Ptc Therapeutics, Inc. Heteroaryl compounds for treating Huntington's disease
WO2020163405A1 (en) 2019-02-05 2020-08-13 Skyhawk Therapeutics, Inc. Methods and compositions for modulating splicing
JP2022519323A (ja) 2019-02-06 2022-03-22 スカイホーク・セラピューティクス・インコーポレーテッド スプライシングを調節するための方法および組成物
US11129829B2 (en) 2019-06-17 2021-09-28 Skyhawk Therapeutics, Inc. Methods for modulating splicing
CA3156848A1 (en) 2019-11-01 2021-05-06 Novartis Ag The use of a splicing modulator for a treatment slowing progression of huntington's disease
WO2021222366A1 (en) * 2020-04-28 2021-11-04 Kymera Therapeutics, Inc. Irak inhibitors and uses thereof
IL298109A (en) 2020-05-13 2023-01-01 Chdi Foundation Inc htt modulators for the treatment of Huntington's disease
EP4178963A1 (en) 2020-07-02 2023-05-17 Remix Therapeutics Inc. 5-[5-(piperidin-4-yl)thieno[3,2-c]pyrazol-2-yl]indazole derivatives and related compounds as modulators for splicing nucleic acids and for the treatment of proliferative diseases
JP2023532332A (ja) 2020-07-02 2023-07-27 リミックス セラピューティクス インコーポレイテッド 核酸のスプライシング及び増殖性疾患の処置のためのモジュレーターとしての2-(インダゾール-5-イル)-6-(ピペリジン-4-イル)-1,7-ナフチリジン誘導体及び関連する化合物
CN116981674A (zh) * 2021-03-17 2023-10-31 豪夫迈·罗氏有限公司 新的噻唑并嘧啶酮衍生物
JP2024510487A (ja) * 2021-03-17 2024-03-07 エフ. ホフマン-ラ ロシュ アーゲー 新規なチアジアゾロピリミドン誘導体
JP2024510004A (ja) * 2021-03-17 2024-03-05 エフ. ホフマン-ラ ロシュ アーゲー 新規チエノピリミジノン誘導体
TW202304446A (zh) 2021-03-29 2023-02-01 瑞士商諾華公司 剪接調節子用於減慢杭丁頓氏舞蹈症進展的治療之用途
CN116262758A (zh) * 2021-12-15 2023-06-16 上海博悦生物科技有限公司 7-甲基噻唑并[5,4-d]嘧啶类化合物、制备方法及其用途
WO2023225244A1 (en) * 2022-05-20 2023-11-23 Biogen Ma Inc. Heterocyclic compounds for treating huntington's disease
WO2024215070A1 (ko) * 2023-04-11 2024-10-17 보로노이 주식회사 피라졸로피리딘 유도체 화합물 및 이의 용도
WO2024218207A1 (en) * 2023-04-20 2024-10-24 F. Hoffmann-La Roche Ag Thieno[3,2-b]pyridine derivatives

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004019002A2 (en) * 2002-08-23 2004-03-04 The Board Of Trustees Of The Leland Stanford Junior University Fluorescent glycosides and methods for their use
US7473784B2 (en) * 2005-08-01 2009-01-06 Bristol-Myers Squibb Company Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors
CN101410385B (zh) * 2006-03-28 2011-08-24 高点制药有限责任公司 具有组胺h3受体活性的苯并噻唑类
US8153813B2 (en) * 2007-12-20 2012-04-10 Abbott Laboratories Benzothiazole and benzooxazole derivatives and methods of use
US8993580B2 (en) * 2008-03-14 2015-03-31 Intellikine Llc Benzothiazole kinase inhibitors and methods of use
WO2009126635A1 (en) * 2008-04-09 2009-10-15 Abbott Laboratories 2-amino-benzothiazole derivates useful as inhibitors of rock kinases
WO2010024903A1 (en) * 2008-08-29 2010-03-04 Yangbo Feng BENZO[d]OXAZOLES AND BENZO[d]THIAZOLES AS KINASE INHIBITORS
EP2379564A1 (en) * 2008-12-19 2011-10-26 Schering Corporation Bicyclic heterocyclic derivatives and methods of use thereof
BR112012028445A2 (pt) * 2010-05-06 2016-07-19 Bristol Myers Squibb Co compostos de heteroarila bicíclica como moduladores de gpr119
US20130046093A1 (en) * 2011-08-18 2013-02-21 Korea Institute Of Science And Technology Pharmaceutical compositions for preventing or treating degenerative brain disease and method of screening the same
US20180282347A1 (en) * 2014-12-02 2018-10-04 Bayer Cropscience Aktiengesellschaft Bicyclic compounds as pest control agents
CN107635984B (zh) * 2015-03-11 2021-04-13 Fmc公司 杂环取代的二环唑杀有害生物剂
CA3119019C (en) * 2015-12-10 2024-06-11 Ptc Therapeutics, Inc. Compounds and methods for treating huntington's disease
CN109071528B (zh) * 2016-03-11 2023-02-17 Ac免疫有限公司 用于诊断和治疗的双环化合物
US10526345B2 (en) * 2016-04-08 2020-01-07 Mankind Pharma Ltd. Compounds as GPR119 agonists
ES2800313T3 (es) * 2016-07-14 2020-12-29 Bristol Myers Squibb Co Compuestos de heteroarilo bicíclico sustituidos

Similar Documents

Publication Publication Date Title
JPWO2020005877A5 (pt)
JP7399869B2 (ja) ハンチントン病を処置するための化合物
JP2020522570A5 (pt)
JPWO2019191229A5 (pt)
JPWO2019191092A5 (pt)
AU2019203444B2 (en) Bicyclic lactams and methods of use thereof
JPWO2020005873A5 (pt)
CN114245794B (zh) 用于治疗亨廷顿氏病的化合物
KR101812357B1 (ko) Cdk4/6의 억제제로서의 피롤로피리미딘 화합물
HRP20210177T1 (hr) Supstituirani spojevi pirazolo[1,5-a]piridina kao inhibitori ret kinaze
JP2021503004A5 (pt)
JP2024105367A (ja) ハンチントン病を処置するためのヘテロアリール化合物
JP2015504057A5 (pt)
JP2014506929A5 (pt)
WO2020005882A1 (en) Heteroaryl compounds for treating huntington's disease
HRP20151232T1 (hr) Derivati 2,3-dihidro-1h-inden-1-il-2,7-diazaspiro[3.6]nonana i njihova upotreba kao antagonista ili inverznih agonista grelinskog receptora
JP2011500774A5 (pt)
JP2015537010A5 (pt)
JP2015508075A5 (pt)
JP2011511034A5 (pt)
RU2015122895A (ru) Пуриновые ингибиторы человеческой фосфатидилинозит 3-киназы дельта
CA2649521A1 (en) Novel piperazine compound, and use thereof as hcv polymerase inhibitor
IL297044A (en) Compounds for the treatment of Huntington's disease
JPWO2020231977A5 (pt)
JPWO2020065614A5 (pt)